Last reviewed: June 12, 2026
Last updated: June 12, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide injection has emerged as one of the most effective weight loss medications available, with clinical evidence demonstrating substantial fat reduction in patients with obesity and overweight conditions. The amount of weight you lose depends on multiple factors including your starting weight, metabolism, lifestyle changes, and how your body responds to the medication. Understanding realistic expectations and what drives individual variation helps you make an informed decision about treatment.
Average Weight Loss Results from Semaglutide Clinical Trials
The STEP clinical trials, which tested semaglutide in patients with obesity, revealed compelling weight loss data across different dosing schedules. Participants receiving semaglutide at the maximum dose lost approximately 15% of their baseline body weight over 68 weeks, compared to 2.4% weight loss in the placebo group. This 12-percentage-point difference represents a clinically meaningful improvement that translates to significant health outcomes for most patients.
Real-world results from clinical practice often align with trial findings, though individual outcomes vary considerably. A patient starting at 250 pounds might lose 30-50 pounds over the first year, while another starting at 350 pounds could lose 50-80 pounds with similar adherence and lifestyle modifications. The percentage of body weight lost tends to be more consistent than absolute pound loss, making it a better predictor of your personal outcome.
Timeline of Weight Loss: When Do Results Appear?
Weight loss typically begins within the first 2-4 weeks of starting semaglutide injection, though most patients report the most noticeable changes between weeks 4-12. During this initial phase, appetite suppression becomes pronounced as the medication reaches therapeutic levels in your system. Many patients describe eating smaller portions naturally without feeling deprived, which supports sustained weight loss over months.
The majority of weight loss occurs during the first 6 months of treatment, with continued but slower loss through 12-18 months. After the first year, weight stabilizes for many patients if they maintain their current dose and lifestyle habits. Some individuals experience additional loss between months 12-24, particularly if their dose was increased or lifestyle changes were intensified during the first year.
Factors That Influence How Much Weight You'll Lose
Your starting weight, age, sex, and baseline metabolic rate all affect the magnitude of weight loss you can expect. Patients with higher starting weights often experience greater absolute pound loss, while those with lower starting weights may see smaller numbers but comparable percentage reductions. Age plays a role because metabolism naturally slows with years, potentially affecting the rate of loss, though semaglutide remains effective across all age groups studied.
Genetic variation in how your body processes hunger signals and regulates energy use significantly impacts treatment response. PlexusDx's Precision Peptide Genetic Test identifies key variants in genes like GLP1R, GIPR, FTO, and MC4R that predict how responsive your metabolism will be to semaglutide therapy. Understanding these genetic predispositions helps set realistic goals and may inform whether you're a candidate for alternative or combination therapies.
Lifestyle adherence—including diet quality, physical activity, and sleep—compounds the medication's effects substantially. Patients who combine semaglutide with reduced calorie intake and regular movement typically lose more weight and maintain losses longer than those relying solely on the medication. Alcohol consumption, stress management, and consistency with injection timing also influence outcomes.
Semaglutide Injection vs. Oral: Which Produces Better Results?
Semaglutide injection delivers medication directly into subcutaneous tissue, allowing consistent absorption and typically producing more robust appetite suppression than oral formulations. Clinical data shows injectable semaglutide achieves higher bioavailability, meaning more of the active compound reaches your system compared to oral tablets. This pharmacokinetic advantage often translates to faster onset of effects and greater weight loss magnitude in direct comparisons.
PlexusDx offers both semaglutide injection starting at $149 per month and oral semaglutide at $249 per month, allowing you to choose based on preference, convenience, and expected efficacy. Injection therapy requires once-weekly administration, while oral dosing is daily, making compliance easier for some patients. If you've tried oral semaglutide with modest results, switching to the injection form frequently produces more substantial weight loss responses.
Maintaining Weight Loss After Reaching Your Goal
Weight loss maintenance with semaglutide requires ongoing treatment rather than a fixed-duration course. Clinical evidence indicates that patients who discontinue the medication typically regain 40-50% of the weight lost within one year after stopping. This rebound occurs because the underlying metabolic and appetite regulation factors that necessitated treatment remain present after medication stops.
Many patients choose to continue semaglutide indefinitely at a maintenance dose, which is typically lower than the dose used for active weight loss. PlexusDx structures pricing so your dose can increase without your monthly cost changing, supporting the flexibility to adjust treatment as needed throughout your weight loss journey. Combining ongoing medication with sustained lifestyle modifications maximizes long-term success and prevents regain.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I expect to lose 100 pounds or more with semaglutide injection?
Losing 100 pounds with semaglutide is possible for patients starting with significantly higher body weights, though outcomes vary widely based on starting weight, genetics, and adherence. Clinical trials show approximately 15% average body weight loss, which means a 300-pound patient might lose 45 pounds, while a 400-pound patient could lose 60 pounds or more. PlexusDx's Precision Peptide Genetic Test can help identify whether you're genetically predisposed to stronger treatment response.
How does semaglutide cause weight loss at the biological level?
Semaglutide works as a GLP-1 receptor agonist, mimicking a natural hormone that tells your brain you're full and satisfied with less food. It slows stomach emptying, reduces appetite signals from the hypothalamus, and increases feelings of fullness and satiety. This combination of effects reduces overall calorie intake without requiring willpower-dependent restriction, making sustainable weight loss more achievable.
What is the cost of semaglutide injection at PlexusDx?
PlexusDx offers compounded semaglutide injection starting at $149 per month across three commitment tiers, with your dose able to increase without your price changing. The medication comes from licensed 503A compounding pharmacies and is available to all 50 states without requiring insurance or membership fees. HSA and FSA accounts are eligible for reimbursement, making treatment even more accessible.
What are the common side effects of semaglutide injection, and do they affect weight loss?
Nausea is the most frequently reported side effect, typically occurring during dose escalation and usually subsiding within 1-2 weeks. Other common effects include vomiting, constipation, diarrhea, and decreased appetite—the latter actually supporting weight loss goals. Serious side effects are rare but include severe pancreatitis or gallbladder issues; report any severe abdominal pain to your provider immediately.
How can I know if my genetics make me a good candidate for semaglutide?
PlexusDx's Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that predict your metabolic response to semaglutide and similar therapies. This $99 add-on test after your first month of treatment maps 14 pathways and 150+ genetic insights specific to peptide-based weight loss. Results help your provider optimize your treatment protocol and may suggest alternatives if your genetic profile indicates limited semaglutide responsiveness.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Compounded Semaglutide Better Than Ozempic?
NAD+ vs Semaglutide — Mechanisms, Results & Clinical Reality